Financing Cash Flow

-$2.20B

TTM · Period ending: Jun 30, 2026 · USD

VRTX Financing Cash Flow

Latest reported-$2.20Bperiod endingJun 30, 2026

VRTX TTM Cash from Financing (-$1.20M → -$2.20B)

TTM financing cash flow

High-resolution chart · PNG

VRTX financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Vertex Pharmaceuticals Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period ending	Financing Cash Flow (USD)
Jun 30, 2026	-2,197,200,000
Mar 31, 2026	-2,119,700,000
Dec 31, 2025	-2,261,300,000
Sep 30, 2025	-2,575,400,000
Jun 30, 2025	-1,808,400,000
Mar 31, 2025	-1,817,800,000
Dec 31, 2024	-1,494,900,000
Sep 30, 2024	-1,223,400,000
Jun 30, 2024	-1,000,900,000
Mar 31, 2024	-625,000,000
Dec 31, 2023	-562,200,000
Sep 30, 2023	-402,200,000
Jun 30, 2023	-297,400,000
Mar 31, 2023	-267,000,000
Dec 31, 2022	-67,700,000
Sep 30, 2022	-444,135,000
Jun 30, 2022	-1,040,596,000
Mar 31, 2022	-1,054,746,000
Dec 31, 2021	-1,478,000,000
Sep 30, 2021	-1,266,957,000
Jun 30, 2021	-750,980,000
Mar 31, 2021	-664,505,000
Dec 31, 2020	-505,281,000
Sep 30, 2020	-218,668,000
Jun 30, 2020	-57,628,000
Mar 31, 2020	-190,668,000
Dec 31, 2019	126,773,000
Sep 30, 2019	-135,694,000
Jun 30, 2019	-153,971,000
Mar 31, 2019	-192,164,000
Dec 31, 2018	-71,219,000
Sep 30, 2018	103,058,000
Jun 30, 2018	253,684,000
Mar 31, 2018	436,925,000
Dec 31, 2017	68,404,000
Sep 30, 2017	88,935,000
Jun 30, 2017	-50,216,000
Mar 31, 2017	-160,996,000
Dec 31, 2016	133,271,000
Sep 30, 2016	137,306,000
Jun 30, 2016	158,371,000
Mar 31, 2016	158,262,000
Dec 31, 2015	188,919,000
Sep 30, 2015	147,444,000
Jun 30, 2015	470,058,000
Mar 31, 2015	482,319,000
Dec 31, 2014	497,376,000
Sep 30, 2014	457,579,000
Jun 30, 2014	113,352,000
Mar 31, 2014	237,435,000
Dec 31, 2013	180,884,000
Sep 30, 2013	169,196,000
Jun 30, 2013	164,340,000
Mar 31, 2013	144,544,000
Dec 31, 2012	172,204,000
Sep 30, 2012	-15,613,000
Jun 30, 2012	-3,694,000
Mar 31, 2012	-86,356,000
Dec 31, 2011	-124,238,000
Sep 30, 2011	68,189,000
Jun 30, 2011	446,615,000
Mar 31, 2011	401,058,000
Dec 31, 2010	425,057,000
Sep 30, 2010	954,274,000
Jun 30, 2010	686,372,000
Mar 31, 2010	687,980,000
Dec 31, 2009	999,006,000
Sep 30, 2009	474,057,000
Jun 30, 2009	568,426,000
Mar 31, 2009	547,427,000
Dec 31, 2008	620,738,000
Sep 30, 2008	617,750,000
Jun 30, 2008	360,391,000
Mar 31, 2008	378,445,000
Dec 31, 2007	-10,190,000
Sep 30, 2007	-6,615,000
Jun 30, 2007	345,636,000
Mar 31, 2007	347,049,000
Dec 31, 2006	365,865,000
Sep 30, 2006	367,204,000
Jun 30, 2006	59,119,000
Mar 31, 2006	219,044,000
Dec 31, 2005	197,456,000
Sep 30, 2005	185,293,000
Jun 30, 2005	172,430,000
Mar 31, 2005	-7,993,000
Dec 31, 2004	-8,626,000
Sep 30, 2004	4,576,000
Jun 30, 2004	14,644,000
Mar 31, 2004	26,397,000
Dec 31, 2003	37,468,000
Sep 30, 2003	27,436,000
Jun 30, 2003	19,295,000
Mar 31, 2003	23,269,000
Dec 31, 2002	13,842,000
Sep 30, 2002	-9,424,000
Jun 30, 2002	-7,892,000
Mar 31, 2002	-9,990,000
Dec 31, 2001	-3,982,000
Sep 30, 2001	23,234,000